Department of Physiology, Showa University School of Medicine, Tokyo, Japan.
Department of Legal Medicine, Showa University School of Medicine, Tokyo, Japan.
J Ethnopharmacol. 2021 Aug 10;276:114218. doi: 10.1016/j.jep.2021.114218. Epub 2021 May 23.
Kamikihito (KKT) is a Kampo medicine that is prescribed in Japan for the treatment of anemia, insomnia and mental anxiety in Japan. However, its precise mechanism of action remains unclear.
This study aimed to evaluate the possible antistress effect of KKT in rats with acute stress and the contribution of oxytocin to the process.
Acute immobilization stress (AIS; for 90 min) was used to assess the effect of KKT on acute stress. Male Wistar rats were orally treated with KKT. Parameters of stress were evaluated, and concentrations of oxytocin in plasma and cerebrospinal fluid (CSF) were measured.
AIS-induced defecation and fecal weight were significantly decreased because of treatment with KKT. The plasma levels of stress-related hormones following AIS were investigated. The pre-administration of KKT significantly increased adrenocorticotrophic hormone (ACTH) and corticosterone (CORT) levels following AIS. Conversely, there was no significant change in the plasma oxytocin level. Microdialysis and hydrophilic interaction liquid chromatography-tandem mass spectrometry (HILIC-MS/MS) were used to monitor the oxytocin secretion in CSF. Oxytocin level increased during AIS following the treatment of KKT. At 30 min after AIS, the level remained higher than before AIS. Furthermore, using an open field test, the locomotion (exploratory behavior) immediately after AIS was examined. The total traveled distance decreased after AIS; however, the decrease was significantly inhibited by the treatment of KKT. However, the effect of KKT was obstructed by the pre-administration of the oxytocin receptor antagonist.
These results suggest that KKT has antistress activity and increased oxytocin secretion may be a mechanism underlying this phenomenon.
万金油(KKT)是一种日本汉方药,用于治疗日本的贫血、失眠和精神焦虑症。然而,其确切的作用机制尚不清楚。
本研究旨在评估 KKT 对急性应激大鼠的可能抗应激作用及其对催产素的贡献。
采用急性束缚应激(AIS;90 分钟)评估 KKT 对急性应激的影响。雄性 Wistar 大鼠口服 KKT。评估应激参数,并测量血浆和脑脊液(CSF)中催产素的浓度。
由于 KKT 的治疗,AIS 诱导的排便和粪便重量显著减少。研究了 AIS 后应激相关激素的血浆水平。KKT 的预先给药显著增加了 AIS 后的促肾上腺皮质激素(ACTH)和皮质酮(CORT)水平。相反,血浆催产素水平没有显著变化。微透析和亲水相互作用液相色谱-串联质谱(HILIC-MS/MS)用于监测 CSF 中催产素的分泌。KKT 治疗后,AIS 期间催产素水平增加。在 AIS 后 30 分钟,水平仍高于 AIS 前。此外,通过旷场试验,检查 AIS 后立即的运动(探索行为)。AIS 后总行驶距离减少,但 KKT 的治疗显著抑制了这种减少。然而,KKT 的作用被催产素受体拮抗剂的预先给药所阻断。
这些结果表明 KKT 具有抗应激活性,催产素分泌的增加可能是这种现象的机制之一。